Prague municipal court rules for Zentiva, against Pfizer, says may Czech company may continue distribution of anti- cholesterol drug

A Prague court has ruled that the Czech generic drugs maker Zentiva may resume distributing its anti-cholesterol drug, overturning an earlier ban imposed as part of a dispute with US drug giant Pfizer. The court had earlier banned the Czech company from distributing it's a-tor-vast-a-tin drug after complaints from Pfizer about its marketing campaign. Zentiva's drug is a generic version of Pfizer's Sortis, whose patent expired last month.